Skip to content

Clinical trials

Completed Waldenstrom Macroglobulinemia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Status: Completed Country / region: France Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20082
20091
20111
20141
20162
20172
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Eli Lilly and Company2
Assistance Publique - Hôpitaux de Paris1
BeiGene1
Central Hospital, Nancy, France1
French Innovative Leukemia Organisation1
French Study Group on Chronic Lymphoid Leukemia1
Gilead Sciences1
Loxo Oncology, Inc.1
Pharmacyclics LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia16
Lymphoma, B-Cell, Marginal Zone9
Lymphoma, Non-Hodgkin9
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma, Follicular7
Lymphoma, Mantle-Cell7
Multiple Myeloma6
Burkitt Lymphoma5
Leukemia, Hairy Cell5
Lymphoma, Large B-Cell, Diffuse5

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.